|
[1] KRAUSE A,HABERKORN U,MIER W. Strategies for the treatment of HBV/HDV[J]. Eur J Pharmacol,2018,833:379-391.
|
|
[2] TACKE F. Current and future therapy of hepatitis B and D[J].Dtsch Med Wochenschr,2019,144(8):528-534.
|
|
[3] CAI J,HAN T,NIE C,et al. Biomarkers of oxidation stress,inflammation,necrosis and apoptosis are associated with hepatitis B-related acute-on-chronic liver failure[J]. Clin Res Hepatol Gastroenterol,2016,40(1):41-50.
|
|
[4] FERRARI S,FINELLI P,ROCCHI M,et al. The active gene that encodes human high mobility group 1 protein(HMG1)contains introns and maps to chromosome 13[J]. Genomics,1996,35(2):367-371.
|
|
[5] JIA L,CLEAR A,LIU FT,et al. Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia[J]. Blood,2014,123(11):1709-1719.
|
|
[6] ANDERSSON U,TRACEY KJ. HMGB1 is a therapeutic target for sterile inflammation and infection[J]. Annu Rev Immunol,2011,29:139-162.
|
|
[7] WEIR HM,KRAULIS PJ,HILL CS,et al. Structure of the HMG box motif in the B-domain of HMG1[J]. EMBO J,1993,12(4):1311-1319.
|
|
[8] JIANG Y,STEINLE JJ. HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells[J]. Growth Factors,2018,36(3-4):164-171.
|
|
[9] LOTZE MT,TRACEY KJ. High-mobility group box 1 protein(HMGB1):Nuclear weapon in the immune arsenal[J]. Nat Rev Immunol,2005,5(4):331-342.
|
|
[10] LI J,KOKKOLA R,TABIBZADEH S,et al. Structural basis for the proinflammatory cytokine activity of high mobility group box1[J]. Mol Med,2003,9(1-2):37-45.
|
|
[11] CATO L,STOTT K,WATSON M,et al. The interaction of HMGB1 and linker histones occurs through their acidic and basic tails[J]. J Mol Biol,2008,384(5):1262-1272.
|
|
[12] CALOGERO S,GRASSI F,AGUZZI A,et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice[J]. Nat Genet,1999,22(3):276-280.
|
|
[13] CIUCCI A,GABRIELE I,PERCARIO ZA. HMGB1 and cord blood:Its role as immuno-adjuvant factor in innate immunity[J]. PLo S One,2011,6(8):e23766.
|
|
[14] HREGGVIDSDOTTIR HS,OSTBERG T,WAHAMAA H,et al.The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation[J]. J Leukoc Biol,2009,86(3):655-662.
|
|
[15] CHEN RC,YI PP,ZHOU RR,et al. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines[J]. Mol Cel Biochem,2014,390(1-2):271-280.
|
|
[16] ZHANG CL,SHU MG,QI HW,et al. Inhibition of tumor angiogenesis by HMGB1 A box peptide[J]. Med Hypotheses,2008,70(2):343-345.
|
|
[17] KANG R,CHEN R,ZHANG Q,et al. HMGB1 in health and disease[J]. Mol Aspects Med,2014,40:1-116.
|
|
[18] ANDERSSON U,HARRIS HE. The role of HMGB1 in the pathogenesis of rheumatic disease[J]. Biochim Biophys Acta,2010,1799(1-2):141-148.
|
|
[19] LEE H,SHIN N,SONG M,et al. Analysis of nuclear high mobility group box 1(HMGB1)-binding proteins in colon cancer cells:Clustering with proteins involved in secretion and extranuclear function[J]. J Proteome Res,2010,9(9):4661-4670.
|
|
[20] KAZAMA H,RICCI JE,HERNDON JM,et al. Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of high-mobility group box-1 protein[J]. Immunity,2008,29(1):21-32.
|
|
[21] HUDSON BI,CARTER AM,HARJA E,et al. Identification,classification,and expression of RAGE gene splice variants[J]. FASEB J,2008,22(5):1572-1580.
|
|
[22] DEMLING N,EHRHARDT C,KASPER M,et al. Promotion of cell adherence and spreading:A novel function of RAGE,the highly selective differentiation marker of human alveolar epithelial type I cells[J]. Cell Tissue Res,2006,323(3):475-488.
|
|
[23] HE SJ,CHENG J,FENG X,et al. The dual role and therapeutic potential of high-mobility group box 1 in cancer[J]. Oncotarget,2017,8(38):64534-64550.
|
|
[24] XU Y,ZHOU Y,LIN H,et al. Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury[J]. Int J Mol Med,2013,31(3):555-560.
|
|
[25] YANG X,JIANG X,CHEN G,et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response[J]. J Immunol,2013,190(5):2068-2079.
|
|
[26] WONG D,KORZ W. Translating an antagonist of chemokine receptor CXCR4:From bench to bedside[J]. Clin Cancer Res,2008,14(24):7975-7980.
|
|
[27] SCHIRALDI M,RAUCCI A,MUNOZ LM,et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4[J].J Exp Med,2012,209(3):551-563.
|
|
[28] MF AKBAR S,AL MAHTAB M,S IK. Nature of host immunity during hepatitis B virus infection and designing immune therapy[J]. Euroasian J Hepatogastroenterol,2018,8(1):42-46.
|
|
[29] FU S,WANG J,HU X,et al. Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes[J]. Mol Oncol,2018,12(3):322-338.
|
|
[30] LI J,ZENG C,ZHENG B,et al. HMGB1-induced autophagy facilitates hepatic stellate cells activation:A new pathway in liver fibrosis[J]. Clin Sci(Lond),2018,132(15):1645-1667.
|
|
[31] WANG LW,CHEN H,GONG ZJ. High mobility group box-1protein inhibits regulatory T cell immune activity in liver failure in patients with chronic hepatitis B[J]. Hepatobiliary Pancreat Dis Int,2010,9(5):499-507.
|
|
[32] LI G,JIANG Q,XU K. CREB family:A significant role in liver fibrosis[J]. Biochimie,2019,163:94-100.
|
|
[33] KAO YH,JAWAN B,GOTO S,et al. High-mobility group box 1 protein activates hepatic stellate cells in vitro[J]. Transplant Proc,2008,40(8):2704-2705.
|
|
[34] KAO YH,JAWAN B,GOTO S,et al. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells[J]. World J Gastroenterol,2011,17(36):4090-4098.
|
|
[35] HE Q,FU Y,DING X,et al. High-mobility group box 1 induces endoplasmic reticulum stress and activates hepatic stellate cells[J]. Lab Invest,2018,98(9):1200-1210.
|
|
[36] BI MR,ZHU LY,YAN BZ,et al. Association of upregulated HMGB1 and c-IAP2 proteins with hepatocellular carcinoma development and progression[J]. Hepat Mon,2014,14(12):e23552.
|
|
[37] YAN W,CHANG Y,LIANG X,et al. High-mobility group box1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases[J]. Hepatology,2012,55(6):1863-1875.
|
|
[38] CHEN M,LIU Y,VARLEY P,et al. High-mobility group box1 promotes hepatocellular carcinoma progression through mir-21-mediated matrix metalloproteinase activity[J]. Cancer Res,2015,75(8):1645-1656.
|
|
[39] YAN HX,WU HP,ZHANG HL,et al. P53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1release[J]. J Hepatol,2013,59(4):762-768.
|
|
[40] SITIA G,IANNACONE M,MULLER S,et al. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice[J]. J Leukoc Biol,2007,81(1):100-107.
|
|
[41] YANG XY,KANG FB,YE LH,et al. Level of high-mobility group box 1 in patients with chronic hepatitis B and liver cirrhosis and its clinical significance[J]. J Clin Hepatol,2018,34(9):1901-1904.(in Chinese)杨新英，康富标，叶立红，等．慢性乙型肝炎及肝硬化患者血清高迁移率族蛋白B1水平变化及临床意义[J]．临床肝胆病杂志，2018,34(9):1901-1904.
|
|
[42] TU CT,YAO QY,XU BL,et al. Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride:Modulation of high-mobility group box 1,Toll-like receptor 4 and2 expression[J]. Food Chem Toxicol,2012,50(9):3343-3351.
|
|
[43] VENEREAU E,CASALGRANDI M,SCHIRALDI M,et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release[J]. J Exp Med,2012,209(9):1519-1528.
|
|
[44] YANG H,HREGGVIDSDOTTIR HS,PALMBLAD K,et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release[J].Proc Natl Acad Sci U S A,2010,107(26):11942-11947.
|
|
[45] ABEYAMA K,STERN DM,ITO Y,et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1protein,a novel antiinflammatory mechanism[J]. J Clin Invest,2005,115(5):1267-1274.
|
|
[46] XIE K,YU Y,PEI Y,et al. Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release[J]. Shock,2010,34(1):90-97.
|
|
[47] WANG L,ZHANG X,LIU L,et al. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1,HMGB1 receptors(RAGE and TLR4),NF-kappaB expression[J]. Neurosci Lett,2010,471(3):152-156.
|
|
[48] YANG M,CAO L,XIE M,et al. Chloroquine inhibits HMGB1inflammatory signaling and protects mice from lethal sepsis[J]. Biochem Pharmacol,2013,86(3):410-418.
|
|
[49] ULLOA L,OCHANI M,YANG H,et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J]. Proc Natl Acad Sci U S A,2002,99(19):12351-12356.
|
|
[50] WANG H,LI W,LI J,et al. The aqueous extract of a popular herbal nutrient supplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J]. J Nutr,2006,136(2):360-365.
|
|
[51] LI W,LI J,ASHOK M,et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator,high mobility group box 1[J]. J Immunol,2007,178(6):3856-3864.
|
|
[52] LI W,ASHOK M,LI J,et al. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1[J]. PLo S One,2007,2(11):e1153.
|
|
[53] CHENG LS,LI J,LIU Y,et al. HMGB1-induced autophagy:A new pathway to maintain Treg function during chronic hepatitis B virus infection[J]. Clin Sci(Lond),2017,131(5):381-394.
|
|
[54] TANG D,KANG R,ZEH HJ,et al. High-mobility group box1 and cancer[J]. Biochim Biophys Acta,2010,1799(1-2):131-140.
|
DownLoad: